Global Wearables in Pharma & Biotech Market Outlook 2025
The market for wearables in pharma and biotech is witnessing robust growth due to the integration of advanced technologies in healthcare, enabling real-time health monitoring, clinical trial optimization, and improved patient outcomes. Smartwatches, biosensors, and patches are at the forefront, facilitating data-driven decisions and personalized medicine. Pharmaceutical and biotechnology companies are leveraging wearables for patient engagement, adherence improvement, and remote disease management, underscoring their role in digital health transformation.
Latest Market Dynamics
Key Drivers
Rising adoption of wearables in remote patient monitoring, driven by increased demand for digitized healthcare solutions and ongoing prevalence of chronic diseases. For instance, Philips Healthcare expanded its remote patient monitoring capabilities with advanced biosensors in June 2024.
Growing utilization of wearable devices in clinical trials to enhance data accuracy and reduce trial costs. In 2024, Medtronic launched a wearable platform integrating real-time data collection to streamline decentralized trials across therapeutic areas.
Key Trends
Integration of Artificial Intelligence (AI) with wearable devices for predictive analytics and personalized treatment, as seen in the latest Fitbit (Google) collaboration with health tech platforms announced in July 2024.
Increasing partnerships between pharma/biotech firms and technology companies to co-develop innovative biosensor wearables, exemplified by Abbott Laboratories' June 2024 partnership with Samsung to deliver next-gen diagnostic wearables.
Key Opportunities
Expansion into emerging markets where wearables penetration is rapidly increasing, with companies such as Huawei launching affordable smart health monitoring solutions in APAC and Africa (August 2024).
Development of disease-specific wearable platforms, like Dexcom's new diabetes biosensor patch launched in July 2024, creates targeted growth opportunities for chronic and rare disease management.
Key Challenges
Data privacy and interoperability concerns persist, with regulatory bodies urging stricter compliance; Apple updated its HealthKit policies in July 2024 to address cross-platform data security.
High cost of advanced wearable devices limits accessibility for smaller healthcare providers and in low-income regions, as highlighted in June 2024 by OMRON's pricing review for its newest biosensor suite.
Key Restraints
Complex regulatory approval processes for new wearable medical devices delay market entry, emphasized by Withings’ July 2024 statement on extended EU MDR clearance timelines.
Limited battery life and device durability issues hinder long-term monitoring; Polar Electro's 2024 recall of a key tracker model over battery performance demonstrates this ongoing restraint.
Smartwatches command the highest market share in the wearables in pharma & biotech sector, accounting for 30% of the distribution. This is followed closely by biosensors, capturing 25%, and patches at 20%. Their versatility in health tracking and continuous data monitoring make smartwatches particularly popular for both clinical and consumer use. Biosensors and patches continue gaining traction for offering discrete and non-invasive monitoring solutions, vital for chronic disease management and decentralized trials. The upward adoption of these device types indicates the market's prioritization of comprehensive health insights and user-friendly interfaces.
Remote patient monitoring is the leading application, making up 32% of the wearables use in pharma & biotech, followed by disease management at 28%, and clinical trials at 18%. The surging need for real-time health insights, especially among patients managing chronic conditions at home, has propelled the growth of remote monitoring solutions. Disease management applications leverage AI-powered analytics to offer proactive interventions, while clinical trials utilize wearable data for improved study accuracy and participant adherence. Collectively, these applications highlight a strategic shift toward data-centric, patient-focused healthcare.
The global revenue for wearables in pharma & biotech experienced significant year-on-year growth, reaching 4,750 Million in 2025 from 3,900 Million in 2024. This upward trajectory is driven by increased adoption of digital health solutions across clinical monitoring and therapeutic interventions. The market is projected to continue its rise, with revenue estimates surpassing 19,200 Million by 2035. Ongoing technological innovations, favorable regulatory landscapes, and growing emphasis on patient-centered care fuel this rapid expansion, securing wearables as a critical component of modern healthcare ecosystems.
Year-on-year (YOY) growth for the wearables market in pharma & biotech has averaged between 10% and 22% during 2020-2025. Following a peak YOY increase of 22% in 2025, attributed to rapid digital transformation and post-pandemic recovery investments, the growth rate is projected to stabilize around 8%-10% from 2027 onwards. This sustained growth is underpinned by ongoing product innovations, broader adoption in decentralized trials, and enhancements in health data analytics. The dynamic growth pattern underscores accelerating market maturity and increasing stakeholder confidence.
North America leads the global wearables in pharma & biotech market, holding 41% share in 2025 due to its established digital infrastructure and strong R&D ecosystem. Europe follows at 27%, benefiting from supportive compliance frameworks and robust healthcare systems. The Asia-Pacific (APAC) region commands 22%, driven by rapid technological adoption, large population base, and proliferative wearable device production. These regions collectively illustrate a concentrated market presence, while Latin America, the Middle East, and Africa represent emerging opportunities as adoption intensifies.
Apple Inc. remains the dominant player with a 17% market share, closely followed by Fitbit (11%), and Philips Healthcare (10%). Withings, Abbott Laboratories, and Medtronic each account for 7-9%, reinforcing the competitive nature of the sector. The diversity among leading companies reflects a mix of tech giants and specialized medtech innovators. Continuous investments into R&D and strategic partnerships have allowed these companies to capture significant market share while fostering innovation across diverse application areas.
Hospitals emerge as the largest buyers, accounting for 34% market share, underlining their critical role in integrating wearables into clinical workflows. Pharmaceutical and biotech companies constitute 28%, utilizing wearables for patient management and clinical trials. Clinics follow at 16%, with distributors and direct-to-consumer channels representing emerging buyer categories. The shift towards institutional and enterprise adoption reflects wearables' pivotal role in driving healthcare digitization and value-based care.
Study Coverage
Metrics
Details
Years
2020-2035
Base Year
2025
Market Size
4750
Regions
North America, Europe, APAC, South America, Middle East, Africa
June 2024: Philips Healthcare released a new remote patient monitoring biosensor, expanding its digital health solutions for heart failure management.
July 2024: Fitbit (Google) announced an AI-powered health analytics partnership to accelerate personalized healthcare delivery.
July 2024: Abbott Laboratories joined forces with Samsung Electronics to launch advanced connected diagnostic wearables in select Asian and European markets.
August 2024: Huawei Technologies rolled out new wearable health monitors designed for the expanding APAC and African healthcare markets.
July 2024: Apple Inc. implemented broader cross-platform data privacy updates for its HealthKit and ResearchKit wearable integrations.
Frequently Asked Questions
About the Author
Alice
Senior Research Consultant
Alice is a Senior Research Consultant specializing in market research, industry analysis, and business consulting across Healthcare. Alice brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Alice has helped organizations translate data into actionable growth strategies.
